These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 31635067)
1. Enhancer Dysfunction in 3D Genome and Disease. Xia JH; Wei GH Cells; 2019 Oct; 8(10):. PubMed ID: 31635067 [TBL] [Abstract][Full Text] [Related]
2. On the identification of potential regulatory variants within genome wide association candidate SNP sets. Chen CY; Chang IS; Hsiung CA; Wasserman WW BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305 [TBL] [Abstract][Full Text] [Related]
3. Regulation of inflammation in diabetes: From genetics to epigenomics evidence. Diedisheim M; Carcarino E; Vandiedonck C; Roussel R; Gautier JF; Venteclef N Mol Metab; 2020 Nov; 41():101041. PubMed ID: 32603690 [TBL] [Abstract][Full Text] [Related]
4. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease. D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306 [TBL] [Abstract][Full Text] [Related]
5. From association to mechanism in complex disease genetics: the role of the 3D genome. Fu Y; Tessneer KL; Li C; Gaffney PM Arthritis Res Ther; 2018 Sep; 20(1):216. PubMed ID: 30268153 [TBL] [Abstract][Full Text] [Related]
6. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus. Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440 [TBL] [Abstract][Full Text] [Related]
7. Disease-Associated Single-Nucleotide Polymorphisms From Noncoding Regions in Juvenile Idiopathic Arthritis Are Located Within or Adjacent to Functional Genomic Elements of Human Neutrophils and CD4+ T Cells. Jiang K; Zhu L; Buck MJ; Chen Y; Carrier B; Liu T; Jarvis JN Arthritis Rheumatol; 2015 Jul; 67(7):1966-77. PubMed ID: 25833190 [TBL] [Abstract][Full Text] [Related]
8. Chromatin landscapes and genetic risk in systemic lupus. Hui-Yuen JS; Zhu L; Wong LP; Jiang K; Chen Y; Liu T; Jarvis JN Arthritis Res Ther; 2016 Dec; 18(1):281. PubMed ID: 27906046 [TBL] [Abstract][Full Text] [Related]
9. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping. Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627 [TBL] [Abstract][Full Text] [Related]
10. Chromosome conformation elucidates regulatory relationships in developing human brain. Won H; de la Torre-Ubieta L; Stein JL; Parikshak NN; Huang J; Opland CK; Gandal MJ; Sutton GJ; Hormozdiari F; Lu D; Lee C; Eskin E; Voineagu I; Ernst J; Geschwind DH Nature; 2016 Oct; 538(7626):523-527. PubMed ID: 27760116 [TBL] [Abstract][Full Text] [Related]
11. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression. Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366 [TBL] [Abstract][Full Text] [Related]
12. Leveraging three-dimensional chromatin architecture for effective reconstruction of enhancer-target gene regulatory interactions. Salviato E; Djordjilović V; Hariprakash JM; Tagliaferri I; Pal K; Ferrari F Nucleic Acids Res; 2021 Sep; 49(17):e97. PubMed ID: 34197622 [TBL] [Abstract][Full Text] [Related]
13. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells. Glinsky GV Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803 [TBL] [Abstract][Full Text] [Related]
14. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer. He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer. Jin HJ; Jung S; DebRoy AR; Davuluri RV Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348 [TBL] [Abstract][Full Text] [Related]
16. Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci. Yan H; Tian S; Kleinstern G; Wang Z; Lee JH; Boddicker NJ; Cerhan JR; Kay NE; Braggio E; Slager SL Hum Mol Genet; 2020 Sep; 29(16):2761-2774. PubMed ID: 32744316 [TBL] [Abstract][Full Text] [Related]
17. Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization. Chepelev I; Wei G; Wangsa D; Tang Q; Zhao K Cell Res; 2012 Mar; 22(3):490-503. PubMed ID: 22270183 [TBL] [Abstract][Full Text] [Related]
18. Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits. Wang M; Hancock TP; MacLeod IM; Pryce JE; Cocks BG; Hayes BJ Genet Sel Evol; 2017 Jul; 49(1):56. PubMed ID: 28683716 [TBL] [Abstract][Full Text] [Related]
19. Integrative Genomic Analysis Predicts Causative Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide enhancer maps link risk variants to disease genes. Nasser J; Bergman DT; Fulco CP; Guckelberger P; Doughty BR; Patwardhan TA; Jones TR; Nguyen TH; Ulirsch JC; Lekschas F; Mualim K; Natri HM; Weeks EM; Munson G; Kane M; Kang HY; Cui A; Ray JP; Eisenhaure TM; Collins RL; Dey K; Pfister H; Price AL; Epstein CB; Kundaje A; Xavier RJ; Daly MJ; Huang H; Finucane HK; Hacohen N; Lander ES; Engreitz JM Nature; 2021 May; 593(7858):238-243. PubMed ID: 33828297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]